Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05778578 · ClinicalTrials.gov registry record · NA
Universal Basic Income and Structural Racism in the US South
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT05778578: Clinical Trial NA study, sponsored by University of Arkansas.
NCT05778578 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 194 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05778578, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
This Stage 3 efficacy study aims to address the critical need for interventions that increase access to appropriate community-based healthcare services, especially for those who have a history of incarceration and inform health policy by testing an intervention that directly reduces the racial income gap by providing a universal basic income (UBI). UBI is intended to promote and protect Black men's health through the influx of capital and subsequent increases in culturally-based protective factors such as personal agency and social connections. Participants will be split into 2 groups: the control and the intervention. Participants in the intervention group will be provided UBI of $500 per month for 6 months to increase healthcare utilization among chronically-ill, low-income Black men.
Primary Outcome
This will be obtained through dichotomous variables yes/no, measured by self-report) adapted from the National Health Interview Survey, collected retrospectively at 6-month and 12-month follow-up timepoints. We also will use medical chart abstraction to confirm self-reported use of healthcare services.
Interventions
- BEHAVIORAL Universal Basic Income
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2023-09-28 |
| Est. Completion | 2025-03-13 |
| Phase | NA |
Why NCT05778578 stopped before completion
NCT05778578 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Universal Basic Income is the first listed.
NCT05778578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05778578 about?
NCT05778578 is a clinical study titled "Universal Basic Income and Structural Racism in the US South". This Stage 3 efficacy study aims to address the critical need for interventions that increase access to appropriate community-based healthcare services, especially for those who have a history of incarceration and inform health policy by testing an intervention that directly reduces the racial incom...
What is the current status of trial NCT05778578?
This trial is currently terminated. It is a NA study. The enrollment target is 194 participants. The study started on 2023-09-28. Estimated completion is 2025-03-13.
What interventions are being tested in trial NCT05778578?
The interventions under investigation include: Universal Basic Income (BEHAVIORAL).
Who is sponsoring clinical trial NCT05778578?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05778578's enrollment target sits among peer trials
194 568th of 2000 higher than 1,432 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI